世界のサイトメガロウイルスアッセイ市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cytomegalovirus Assay Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4094 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、サイトメガロウイルスアッセイの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素免疫測定法（ELISA）、PCRアッセイ、DNAアッセイ、その他）、用途別市場規模（病院、診療所、外来外科センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・サイトメガロウイルスアッセイの市場動向 ・企業の競争状況、市場シェア ・サイトメガロウイルスアッセイの種類別市場規模と予測2016-2027（酵素免疫測定法（ELISA）、PCRアッセイ、DNAアッセイ、その他） ・サイトメガロウイルスアッセイの用途別市場規模と予測2016-2027（病院、診療所、外来外科センター、その他） ・サイトメガロウイルスアッセイの北米市場規模2016-2027（アメリカ、カナダ） ・サイトメガロウイルスアッセイの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・サイトメガロウイルスアッセイのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・サイトメガロウイルスアッセイの中南米市場規模2016-2027（メキシコ、ブラジル） ・サイトメガロウイルスアッセイの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Danaher、BD、bioMerieux、Bio-Rad、Eiken Chemical、ELITech Group、Enzo Biochem、Fujirebio (Miraca Holdings Inc.)、Merck、Qiagen、Abcam、BioVision (Boai NKY Medical Holdings Ltd.)、DiaSorin Molecular、Norgen Biotek） ・結論

Market Analysis and Insights: Global Cytomegalovirus Assay Market
The global Cytomegalovirus Assay market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cytomegalovirus Assay market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cytomegalovirus Assay market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cytomegalovirus Assay market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cytomegalovirus Assay market.

Global Cytomegalovirus Assay Scope and Market Size
Cytomegalovirus Assay market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cytomegalovirus Assay market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Enzyme-Linked Immunosorbent Assays (ELISA)
PCR Assays
DNA Assays
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Danaher
BD
bioMerieux
Bio-Rad
Eiken Chemical
ELITech Group
Enzo Biochem
Fujirebio (Miraca Holdings Inc.)
Merck
Qiagen
Abcam
BioVision (Boai NKY Medical Holdings Ltd.)
DiaSorin Molecular
Norgen Biotek

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cytomegalovirus Assay Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Enzyme-Linked Immunosorbent Assays (ELISA)
1.2.3 PCR Assays
1.2.4 DNA Assays
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cytomegalovirus Assay Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cytomegalovirus Assay Market Perspective (2016-2027)
2.2 Cytomegalovirus Assay Growth Trends by Regions
2.2.1 Cytomegalovirus Assay Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cytomegalovirus Assay Historic Market Share by Regions (2016-2021)
2.2.3 Cytomegalovirus Assay Forecasted Market Size by Regions (2022-2027)
2.3 Cytomegalovirus Assay Industry Dynamic
2.3.1 Cytomegalovirus Assay Market Trends
2.3.2 Cytomegalovirus Assay Market Drivers
2.3.3 Cytomegalovirus Assay Market Challenges
2.3.4 Cytomegalovirus Assay Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cytomegalovirus Assay Players by Revenue
3.1.1 Global Top Cytomegalovirus Assay Players by Revenue (2016-2021)
3.1.2 Global Cytomegalovirus Assay Revenue Market Share by Players (2016-2021)
3.2 Global Cytomegalovirus Assay Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cytomegalovirus Assay Revenue
3.4 Global Cytomegalovirus Assay Market Concentration Ratio
3.4.1 Global Cytomegalovirus Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cytomegalovirus Assay Revenue in 2020
3.5 Cytomegalovirus Assay Key Players Head office and Area Served
3.6 Key Players Cytomegalovirus Assay Product Solution and Service
3.7 Date of Enter into Cytomegalovirus Assay Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cytomegalovirus Assay Breakdown Data by Type
4.1 Global Cytomegalovirus Assay Historic Market Size by Type (2016-2021)
4.2 Global Cytomegalovirus Assay Forecasted Market Size by Type (2022-2027)

5 Cytomegalovirus Assay Breakdown Data by Application
5.1 Global Cytomegalovirus Assay Historic Market Size by Application (2016-2021)
5.2 Global Cytomegalovirus Assay Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cytomegalovirus Assay Market Size (2016-2027)
6.2 North America Cytomegalovirus Assay Market Size by Type
6.2.1 North America Cytomegalovirus Assay Market Size by Type (2016-2021)
6.2.2 North America Cytomegalovirus Assay Market Size by Type (2022-2027)
6.2.3 North America Cytomegalovirus Assay Market Size by Type (2016-2027)
6.3 North America Cytomegalovirus Assay Market Size by Application
6.3.1 North America Cytomegalovirus Assay Market Size by Application (2016-2021)
6.3.2 North America Cytomegalovirus Assay Market Size by Application (2022-2027)
6.3.3 North America Cytomegalovirus Assay Market Size by Application (2016-2027)
6.4 North America Cytomegalovirus Assay Market Size by Country
6.4.1 North America Cytomegalovirus Assay Market Size by Country (2016-2021)
6.4.2 North America Cytomegalovirus Assay Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cytomegalovirus Assay Market Size (2016-2027)
7.2 Europe Cytomegalovirus Assay Market Size by Type
7.2.1 Europe Cytomegalovirus Assay Market Size by Type (2016-2021)
7.2.2 Europe Cytomegalovirus Assay Market Size by Type (2022-2027)
7.2.3 Europe Cytomegalovirus Assay Market Size by Type (2016-2027)
7.3 Europe Cytomegalovirus Assay Market Size by Application
7.3.1 Europe Cytomegalovirus Assay Market Size by Application (2016-2021)
7.3.2 Europe Cytomegalovirus Assay Market Size by Application (2022-2027)
7.3.3 Europe Cytomegalovirus Assay Market Size by Application (2016-2027)
7.4 Europe Cytomegalovirus Assay Market Size by Country
7.4.1 Europe Cytomegalovirus Assay Market Size by Country (2016-2021)
7.4.2 Europe Cytomegalovirus Assay Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cytomegalovirus Assay Market Size (2016-2027)
8.2 Asia-Pacific Cytomegalovirus Assay Market Size by Type
8.2.1 Asia-Pacific Cytomegalovirus Assay Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cytomegalovirus Assay Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cytomegalovirus Assay Market Size by Type (2016-2027)
8.3 Asia-Pacific Cytomegalovirus Assay Market Size by Application
8.3.1 Asia-Pacific Cytomegalovirus Assay Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cytomegalovirus Assay Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cytomegalovirus Assay Market Size by Application (2016-2027)
8.4 Asia-Pacific Cytomegalovirus Assay Market Size by Region
8.4.1 Asia-Pacific Cytomegalovirus Assay Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cytomegalovirus Assay Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cytomegalovirus Assay Market Size (2016-2027)
9.2 Latin America Cytomegalovirus Assay Market Size by Type
9.2.1 Latin America Cytomegalovirus Assay Market Size by Type (2016-2021)
9.2.2 Latin America Cytomegalovirus Assay Market Size by Type (2022-2027)
9.2.3 Latin America Cytomegalovirus Assay Market Size by Type (2016-2027)
9.3 Latin America Cytomegalovirus Assay Market Size by Application
9.3.1 Latin America Cytomegalovirus Assay Market Size by Application (2016-2021)
9.3.2 Latin America Cytomegalovirus Assay Market Size by Application (2022-2027)
9.3.3 Latin America Cytomegalovirus Assay Market Size by Application (2016-2027)
9.4 Latin America Cytomegalovirus Assay Market Size by Country
9.4.1 Latin America Cytomegalovirus Assay Market Size by Country (2016-2021)
9.4.2 Latin America Cytomegalovirus Assay Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cytomegalovirus Assay Market Size (2016-2027)
10.2 Middle East & Africa Cytomegalovirus Assay Market Size by Type
10.2.1 Middle East & Africa Cytomegalovirus Assay Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cytomegalovirus Assay Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cytomegalovirus Assay Market Size by Type (2016-2027)
10.3 Middle East & Africa Cytomegalovirus Assay Market Size by Application
10.3.1 Middle East & Africa Cytomegalovirus Assay Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cytomegalovirus Assay Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cytomegalovirus Assay Market Size by Application (2016-2027)
10.4 Middle East & Africa Cytomegalovirus Assay Market Size by Country
10.4.1 Middle East & Africa Cytomegalovirus Assay Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cytomegalovirus Assay Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Cytomegalovirus Assay Introduction
11.1.4 Abbott Revenue in Cytomegalovirus Assay Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Danaher
11.2.1 Danaher Company Details
11.2.2 Danaher Business Overview
11.2.3 Danaher Cytomegalovirus Assay Introduction
11.2.4 Danaher Revenue in Cytomegalovirus Assay Business (2016-2021)
11.2.5 Danaher Recent Development
11.3 BD
11.3.1 BD Company Details
11.3.2 BD Business Overview
11.3.3 BD Cytomegalovirus Assay Introduction
11.3.4 BD Revenue in Cytomegalovirus Assay Business (2016-2021)
11.3.5 BD Recent Development
11.4 bioMerieux
11.4.1 bioMerieux Company Details
11.4.2 bioMerieux Business Overview
11.4.3 bioMerieux Cytomegalovirus Assay Introduction
11.4.4 bioMerieux Revenue in Cytomegalovirus Assay Business (2016-2021)
11.4.5 bioMerieux Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Details
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Cytomegalovirus Assay Introduction
11.5.4 Bio-Rad Revenue in Cytomegalovirus Assay Business (2016-2021)
11.5.5 Bio-Rad Recent Development
11.6 Eiken Chemical
11.6.1 Eiken Chemical Company Details
11.6.2 Eiken Chemical Business Overview
11.6.3 Eiken Chemical Cytomegalovirus Assay Introduction
11.6.4 Eiken Chemical Revenue in Cytomegalovirus Assay Business (2016-2021)
11.6.5 Eiken Chemical Recent Development
11.7 ELITech Group
11.7.1 ELITech Group Company Details
11.7.2 ELITech Group Business Overview
11.7.3 ELITech Group Cytomegalovirus Assay Introduction
11.7.4 ELITech Group Revenue in Cytomegalovirus Assay Business (2016-2021)
11.7.5 ELITech Group Recent Development
11.8 Enzo Biochem
11.8.1 Enzo Biochem Company Details
11.8.2 Enzo Biochem Business Overview
11.8.3 Enzo Biochem Cytomegalovirus Assay Introduction
11.8.4 Enzo Biochem Revenue in Cytomegalovirus Assay Business (2016-2021)
11.8.5 Enzo Biochem Recent Development
11.9 Fujirebio (Miraca Holdings Inc.)
11.9.1 Fujirebio (Miraca Holdings Inc.) Company Details
11.9.2 Fujirebio (Miraca Holdings Inc.) Business Overview
11.9.3 Fujirebio (Miraca Holdings Inc.) Cytomegalovirus Assay Introduction
11.9.4 Fujirebio (Miraca Holdings Inc.) Revenue in Cytomegalovirus Assay Business (2016-2021)
11.9.5 Fujirebio (Miraca Holdings Inc.) Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Cytomegalovirus Assay Introduction
11.10.4 Merck Revenue in Cytomegalovirus Assay Business (2016-2021)
11.10.5 Merck Recent Development
11.11 Qiagen
11.11.1 Qiagen Company Details
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Cytomegalovirus Assay Introduction
11.11.4 Qiagen Revenue in Cytomegalovirus Assay Business (2016-2021)
11.11.5 Qiagen Recent Development
11.12 Abcam
11.12.1 Abcam Company Details
11.12.2 Abcam Business Overview
11.12.3 Abcam Cytomegalovirus Assay Introduction
11.12.4 Abcam Revenue in Cytomegalovirus Assay Business (2016-2021)
11.12.5 Abcam Recent Development
11.13 BioVision (Boai NKY Medical Holdings Ltd.)
11.13.1 BioVision (Boai NKY Medical Holdings Ltd.) Company Details
11.13.2 BioVision (Boai NKY Medical Holdings Ltd.) Business Overview
11.13.3 BioVision (Boai NKY Medical Holdings Ltd.) Cytomegalovirus Assay Introduction
11.13.4 BioVision (Boai NKY Medical Holdings Ltd.) Revenue in Cytomegalovirus Assay Business (2016-2021)
11.13.5 BioVision (Boai NKY Medical Holdings Ltd.) Recent Development
11.14 DiaSorin Molecular
11.14.1 DiaSorin Molecular Company Details
11.14.2 DiaSorin Molecular Business Overview
11.14.3 DiaSorin Molecular Cytomegalovirus Assay Introduction
11.14.4 DiaSorin Molecular Revenue in Cytomegalovirus Assay Business (2016-2021)
11.14.5 DiaSorin Molecular Recent Development
11.15 Norgen Biotek
11.15.1 Norgen Biotek Company Details
11.15.2 Norgen Biotek Business Overview
11.15.3 Norgen Biotek Cytomegalovirus Assay Introduction
11.15.4 Norgen Biotek Revenue in Cytomegalovirus Assay Business (2016-2021)
11.15.5 Norgen Biotek Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cytomegalovirus Assay Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Enzyme-Linked Immunosorbent Assays (ELISA)
Table 3. Key Players of PCR Assays
Table 4. Key Players of DNA Assays
Table 5. Key Players of Others
Table 6. Global Cytomegalovirus Assay Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cytomegalovirus Assay Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cytomegalovirus Assay Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cytomegalovirus Assay Market Share by Regions (2016-2021)
Table 10. Global Cytomegalovirus Assay Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cytomegalovirus Assay Market Share by Regions (2022-2027)
Table 12. Cytomegalovirus Assay Market Trends
Table 13. Cytomegalovirus Assay Market Drivers
Table 14. Cytomegalovirus Assay Market Challenges
Table 15. Cytomegalovirus Assay Market Restraints
Table 16. Global Cytomegalovirus Assay Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cytomegalovirus Assay Market Share by Players (2016-2021)
Table 18. Global Top Cytomegalovirus Assay Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytomegalovirus Assay as of 2020)
Table 19. Ranking of Global Top Cytomegalovirus Assay Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cytomegalovirus Assay Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cytomegalovirus Assay Product Solution and Service
Table 23. Date of Enter into Cytomegalovirus Assay Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cytomegalovirus Assay Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cytomegalovirus Assay Revenue Market Share by Type (2016-2021)
Table 27. Global Cytomegalovirus Assay Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cytomegalovirus Assay Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cytomegalovirus Assay Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cytomegalovirus Assay Revenue Market Share by Application (2016-2021)
Table 31. Global Cytomegalovirus Assay Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cytomegalovirus Assay Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cytomegalovirus Assay Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cytomegalovirus Assay Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cytomegalovirus Assay Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cytomegalovirus Assay Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cytomegalovirus Assay Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cytomegalovirus Assay Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cytomegalovirus Assay Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cytomegalovirus Assay Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cytomegalovirus Assay Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cytomegalovirus Assay Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cytomegalovirus Assay Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cytomegalovirus Assay Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cytomegalovirus Assay Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cytomegalovirus Assay Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cytomegalovirus Assay Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cytomegalovirus Assay Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cytomegalovirus Assay Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cytomegalovirus Assay Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cytomegalovirus Assay Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cytomegalovirus Assay Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cytomegalovirus Assay Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cytomegalovirus Assay Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cytomegalovirus Assay Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cytomegalovirus Assay Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cytomegalovirus Assay Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cytomegalovirus Assay Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cytomegalovirus Assay Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cytomegalovirus Assay Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cytomegalovirus Assay Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cytomegalovirus Assay Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Cytomegalovirus Assay Product
Table 66. Abbott Revenue in Cytomegalovirus Assay Business (2016-2021) & (US$ Million)
Table 67. Abbott Recent Development
Table 68. Danaher Company Details
Table 69. Danaher Business Overview
Table 70. Danaher Cytomegalovirus Assay Product
Table 71. Danaher Revenue in Cytomegalovirus Assay Business (2016-2021) & (US$ Million)
Table 72. Danaher Recent Development
Table 73. BD Company Details
Table 74. BD Business Overview
Table 75. BD Cytomegalovirus Assay Product
Table 76. BD Revenue in Cytomegalovirus Assay Business (2016-2021) & (US$ Million)
Table 77. BD Recent Development
Table 78. bioMerieux Company Details
Table 79. bioMerieux Business Overview
Table 80. bioMerieux Cytomegalovirus Assay Product
Table 81. bioMerieux Revenue in Cytomegalovirus Assay Business (2016-2021) & (US$ Million)
Table 82. bioMerieux Recent Development
Table 83. Bio-Rad Company Details
Table 84. Bio-Rad Business Overview
Table 85. Bio-Rad Cytomegalovirus Assay Product
Table 86. Bio-Rad Revenue in Cytomegalovirus Assay Business (2016-2021) & (US$ Million)
Table 87. Bio-Rad Recent Development
Table 88. Eiken Chemical Company Details
Table 89. Eiken Chemical Business Overview
Table 90. Eiken Chemical Cytomegalovirus Assay Product
Table 91. Eiken Chemical Revenue in Cytomegalovirus Assay Business (2016-2021) & (US$ Million)
Table 92. Eiken Chemical Recent Development
Table 93. ELITech Group Company Details
Table 94. ELITech Group Business Overview
Table 95. ELITech Group Cytomegalovirus Assay Product
Table 96. ELITech Group Revenue in Cytomegalovirus Assay Business (2016-2021) & (US$ Million)
Table 97. ELITech Group Recent Development
Table 98. Enzo Biochem Company Details
Table 99. Enzo Biochem Business Overview
Table 100. Enzo Biochem Revenue in Cytomegalovirus Assay Business (2016-2021) & (US$ Million)
Table 101. Enzo Biochem Recent Development
Table 102. Fujirebio (Miraca Holdings Inc.) Company Details
Table 103. Fujirebio (Miraca Holdings Inc.) Business Overview
Table 104. Fujirebio (Miraca Holdings Inc.) Cytomegalovirus Assay Product
Table 105. Fujirebio (Miraca Holdings Inc.) Revenue in Cytomegalovirus Assay Business (2016-2021) & (US$ Million)
Table 106. Fujirebio (Miraca Holdings Inc.) Recent Development
Table 107. Merck Company Details
Table 108. Merck Business Overview
Table 109. Merck Cytomegalovirus Assay Product
Table 110. Merck Revenue in Cytomegalovirus Assay Business (2016-2021) & (US$ Million)
Table 111. Merck Recent Development
Table 112. Qiagen Company Details
Table 113. Qiagen Business Overview
Table 114. Qiagen Cytomegalovirus Assay Product
Table 115. Qiagen Revenue in Cytomegalovirus Assay Business (2016-2021) & (US$ Million)
Table 116. Qiagen Recent Development
Table 117. Abcam Company Details
Table 118. Abcam Business Overview
Table 119. Abcam Cytomegalovirus Assay Product
Table 120. Abcam Revenue in Cytomegalovirus Assay Business (2016-2021) & (US$ Million)
Table 121. Abcam Recent Development
Table 122. BioVision (Boai NKY Medical Holdings Ltd.) Company Details
Table 123. BioVision (Boai NKY Medical Holdings Ltd.) Business Overview
Table 124. BioVision (Boai NKY Medical Holdings Ltd.) Cytomegalovirus Assay Product
Table 125. BioVision (Boai NKY Medical Holdings Ltd.) Revenue in Cytomegalovirus Assay Business (2016-2021) & (US$ Million)
Table 126. BioVision (Boai NKY Medical Holdings Ltd.) Recent Development
Table 127. DiaSorin Molecular Company Details
Table 128. DiaSorin Molecular Business Overview
Table 129. DiaSorin Molecular Cytomegalovirus Assay Product
Table 130. DiaSorin Molecular Revenue in Cytomegalovirus Assay Business (2016-2021) & (US$ Million)
Table 131. DiaSorin Molecular Recent Development
Table 132. Norgen Biotek Company Details
Table 133. Norgen Biotek Business Overview
Table 134. Norgen Biotek Cytomegalovirus Assay Product
Table 135. Norgen Biotek Revenue in Cytomegalovirus Assay Business (2016-2021) & (US$ Million)
Table 136. Norgen Biotek Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cytomegalovirus Assay Market Share by Type: 2020 VS 2027
Figure 2. Enzyme-Linked Immunosorbent Assays (ELISA) Features
Figure 3. PCR Assays Features
Figure 4. DNA Assays Features
Figure 5. Others Features
Figure 6. Global Cytomegalovirus Assay Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Cytomegalovirus Assay Report Years Considered
Figure 12. Global Cytomegalovirus Assay Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Cytomegalovirus Assay Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Cytomegalovirus Assay Market Share by Regions: 2020 VS 2027
Figure 15. Global Cytomegalovirus Assay Market Share by Regions (2022-2027)
Figure 16. Global Cytomegalovirus Assay Market Share by Players in 2020
Figure 17. Global Top Cytomegalovirus Assay Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytomegalovirus Assay as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Cytomegalovirus Assay Revenue in 2020
Figure 19. Global Cytomegalovirus Assay Revenue Market Share by Type (2016-2021)
Figure 20. Global Cytomegalovirus Assay Revenue Market Share by Type (2022-2027)
Figure 21. North America Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Cytomegalovirus Assay Market Share by Type (2016-2027)
Figure 23. North America Cytomegalovirus Assay Market Share by Application (2016-2027)
Figure 24. North America Cytomegalovirus Assay Market Share by Country (2016-2027)
Figure 25. United States Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Cytomegalovirus Assay Market Share by Type (2016-2027)
Figure 29. Europe Cytomegalovirus Assay Market Share by Application (2016-2027)
Figure 30. Europe Cytomegalovirus Assay Market Share by Country (2016-2027)
Figure 31. Germany Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Cytomegalovirus Assay Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Cytomegalovirus Assay Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Cytomegalovirus Assay Market Share by Region (2016-2027)
Figure 41. China Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Cytomegalovirus Assay Market Share by Type (2016-2027)
Figure 49. Latin America Cytomegalovirus Assay Market Share by Application (2016-2027)
Figure 50. Latin America Cytomegalovirus Assay Market Share by Country (2016-2027)
Figure 51. Mexico Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Cytomegalovirus Assay Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Cytomegalovirus Assay Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Cytomegalovirus Assay Market Share by Country (2016-2027)
Figure 57. Turkey Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Cytomegalovirus Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Revenue Growth Rate in Cytomegalovirus Assay Business (2016-2021)
Figure 61. Danaher Revenue Growth Rate in Cytomegalovirus Assay Business (2016-2021)
Figure 62. BD Revenue Growth Rate in Cytomegalovirus Assay Business (2016-2021)
Figure 63. bioMerieux Revenue Growth Rate in Cytomegalovirus Assay Business (2016-2021)
Figure 64. Bio-Rad Revenue Growth Rate in Cytomegalovirus Assay Business (2016-2021)
Figure 65. Eiken Chemical Revenue Growth Rate in Cytomegalovirus Assay Business (2016-2021)
Figure 66. ELITech Group Revenue Growth Rate in Cytomegalovirus Assay Business (2016-2021)
Figure 67. Enzo Biochem Revenue Growth Rate in Cytomegalovirus Assay Business (2016-2021)
Figure 68. Fujirebio (Miraca Holdings Inc.) Revenue Growth Rate in Cytomegalovirus Assay Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Cytomegalovirus Assay Business (2016-2021)
Figure 70. Qiagen Revenue Growth Rate in Cytomegalovirus Assay Business (2016-2021)
Figure 71. Abcam Revenue Growth Rate in Cytomegalovirus Assay Business (2016-2021)
Figure 72. BioVision (Boai NKY Medical Holdings Ltd.) Revenue Growth Rate in Cytomegalovirus Assay Business (2016-2021)
Figure 73. DiaSorin Molecular Revenue Growth Rate in Cytomegalovirus Assay Business (2016-2021)
Figure 74. Norgen Biotek Revenue Growth Rate in Cytomegalovirus Assay Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

---